Announcements Trials
Browse Landscape

Phase

Phase 2 22Phase 1/2 10Phase 1 9Phase 3 7Phase 4 2Phase NA 1Phase EARLY_PHASE1 1Phase 2/3 1

Status

Recruiting 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Carcinoma, Transitional Cell 1

Interventions

Zoledronic Acid 15enzalutamide 10Leuprolide 9Goserelin 8bicalutamide 7acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 6Triptorelin Pamoate 6Prednisone 6Nivolumab 6Abiraterone Acetate 6luprolide acetate gel depot 5Sunitinib 5Magnetic Resonance Spectroscopy 5Everolimus 5Dutasteride 5Specimen Handling 4Sodium Chloride 4Propofol 4Prednisolone 4Androgen Antagonists 42-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 4pazopanib 3fluciclovine F-18 3darolutamide 3cabazitaxel 3Trimethoprim, Sulfamethoxazole Drug Combination 3Rocuronium 3Mitomycin 3Midazolam 3Flutamide 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × enfortumab vedotin × Genitourinary × Clear all
NCT06862219 2026-05-28

A Safety Study of Enfortumab Vedotin in Indian Adults With Urothelial Cancer

Astellas Pharma Inc

Phase 4 Recruiting
100 enrolled
Genitourinary

Carcinoma, Transitional Cell

NCT06764095 2026-02-12

Enfortumab Vedotin and Pembrolizumab With Cystectomy and/or Ureterectomy for Locally Advanced or Metastatic Bladder and Upper Urothelial Tract Cancer, CAST-AI Trial

Mayo Clinic

Phase 4 Recruiting
75 enrolled
Genitourinary

Urinary Bladder Neoplasms, Ureteral Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡